Ilika finds alignment as battery sector expectations evolve

Ilika Plc

Ilika’s latest appearance at the Battery Show North America revealed that the company’s position is becoming more relevant as the battery sector moves into a new phase, one defined less by volume and more by differentiation.

In a year where pricing pressure has hammered conventional lithium-ion suppliers, Ilika’s oxide solid-state chemistry stood out not for its visibility but for its timing. The industry is recalibrating. Battery cell costs, especially in China, have dropped sharply. LFP prices alone fell by up to 20% in 2024, setting a bar that Western producers are unlikely to match without compromising margins. For Ilika, that shift makes its long-standing focus on performance and safety a clear strategic advantage. What became obvious at the show was that leading OEMs are no longer looking just for cheaper batteries. They are looking for safer, more compact, longer-lasting solutions, attributes Ilika has prioritised from the start.

The company noted strong interest in its Stereax technology, which targets applications where footprint and safety are critical. That’s no longer a niche conversation. It’s now central to discussions about how to replace incumbent lithium-ion designs without triggering a new set of risks or costs. Meanwhile, the emergence of LMR (lithium manganese rich) cathodes and nickel-light formulations shows that even major cell developers are searching for ways to move beyond legacy materials, and are increasingly open to external innovation to do it.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Search